150 related articles for article (PubMed ID: 29526688)
1. The Lipase Activity of Phospholipase D2 is Responsible for Nigral Neurodegeneration in a Rat Model of Parkinson's Disease.
Mendez-Gomez HR; Singh J; Meyers C; Chen W; Gorbatyuk OS; Muzyczka N
Neuroscience; 2018 May; 377():174-183. PubMed ID: 29526688
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration.
Gorbatyuk OS; Li S; Nguyen FN; Manfredsson FP; Kondrikova G; Sullivan LF; Meyers C; Chen W; Mandel RJ; Muzyczka N
Mol Ther; 2010 Oct; 18(10):1758-68. PubMed ID: 20664530
[TBL] [Abstract][Full Text] [Related]
3. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.
Knapek K; Frondorf K; Post J; Short S; Cox D; Gomez-Cambronero J
Mol Cell Biol; 2010 Sep; 30(18):4492-506. PubMed ID: 20647543
[TBL] [Abstract][Full Text] [Related]
5. A novel phospholipase D2-Grb2-WASp heterotrimer regulates leukocyte phagocytosis in a two-step mechanism.
Kantonen S; Hatton N; Mahankali M; Henkels KM; Park H; Cox D; Gomez-Cambronero J
Mol Cell Biol; 2011 Nov; 31(22):4524-37. PubMed ID: 21930784
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
[TBL] [Abstract][Full Text] [Related]
7. The Grb2/PLD2 interaction is essential for lipase activity, intracellular localization and signaling in response to EGF.
Di Fulvio M; Frondorf K; Henkels KM; Lehman N; Gomez-Cambronero J
J Mol Biol; 2007 Mar; 367(3):814-24. PubMed ID: 17276458
[TBL] [Abstract][Full Text] [Related]
8. The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).
Gomez-Cambronero J
Cell Signal; 2011 Dec; 23(12):1885-95. PubMed ID: 21740967
[TBL] [Abstract][Full Text] [Related]
9. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
10. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
Elson JL; Yates A; Pienaar IS
Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
Gully JC; Sergeyev VG; Bhootada Y; Mendez-Gomez H; Meyers CA; Zolotukhin S; Gorbatyuk MS; Gorbatyuk OS
Neurosci Lett; 2016 Aug; 627():36-41. PubMed ID: 27233218
[TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibitors protect against degeneration of nigral dopaminergic neurons in hemiparkinsonian rats.
Inden M; Kondo J; Kitamura Y; Takata K; Nishimura K; Taniguchi T; Sawada H; Shimohama S
J Pharmacol Sci; 2005 Feb; 97(2):203-11. PubMed ID: 15684568
[TBL] [Abstract][Full Text] [Related]
13. The elucidation of novel SH2 binding sites on PLD2.
Di Fulvio M; Lehman N; Lin X; Lopez I; Gomez-Cambronero J
Oncogene; 2006 May; 25(21):3032-40. PubMed ID: 16407827
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of cell membrane ruffling relies on a phospholipase D2 (PLD2), Grb2 and Rac2 association.
Mahankali M; Peng HJ; Cox D; Gomez-Cambronero J
Cell Signal; 2011 Aug; 23(8):1291-8. PubMed ID: 21419846
[TBL] [Abstract][Full Text] [Related]
15. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
[TBL] [Abstract][Full Text] [Related]
16. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
[TBL] [Abstract][Full Text] [Related]
17. Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson's disease.
Revishchin A; Moiseenko L; Kust N; Bazhenova N; Teslia P; Panteleev D; Kovalzon V; Pavlova G
BMC Neurosci; 2016 Jun; 17(1):34. PubMed ID: 27286696
[TBL] [Abstract][Full Text] [Related]
18. Increased vulnerability of nigral dopamine neurons after expansion of their axonal arborization size through D2 dopamine receptor conditional knockout.
Giguère N; Delignat-Lavaud B; Herborg F; Voisin A; Li Y; Jacquemet V; Anand-Srivastava M; Gether U; Giros B; Trudeau LÉ
PLoS Genet; 2019 Aug; 15(8):e1008352. PubMed ID: 31449520
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism.
Gleave JA; Arathoon LR; Trinh D; Lizal KE; Giguère N; Barber JHM; Najarali Z; Khan MH; Thiele SL; Semmen MS; Koprich JB; Brotchie JM; Eubanks JH; Trudeau LE; Nash JE
Neurobiol Dis; 2017 Oct; 106():133-146. PubMed ID: 28673739
[TBL] [Abstract][Full Text] [Related]
20. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
